Biocon Biologics refinances 1.1 billion debt through US dollar bonds and new syndicated facility
Biocon Biologics, a subsidiary of Biocon on Thursday said it refinanced $1.1 billion (Rs 9,347 crore) long term debt through USD bonds and new syndicated facility. This includes $800 million (Rs 6,676.3 crore) senior secured notes due 2029 at a coupon of 6 …